Javascript must be enabled to continue!
GW24-e0047 Gender Difference in Lipoprotein-Associated Phospholipase A2 Activity and Its Association with Cardiovascular Risk Factors
View through CrossRef
Objectives
Lipoprotein-associated phospholipase A2(Lp-PLA2), a proinflammatory enzyme secreted primarily by macrophages, has been shown to be a predictor and potential therapeutic target of cardiovascular disease. The level and distribution of Lp-PLA2 and its associated factors are still unknown for Chinese population. Therefore, we aimed to study the level of Lp-PLA2 activity in men and women in a general population, and to investigate the association of Lp-PLA2 with known cardiovascular risk factors.
Methods
A total of 1471 participants aged 45-74 were recruited from a cohort study in Beijing. Lp-PLA2 activity was determined by a colorimetric assay kit (Cayman Chemical, Ann Arbour, USA). Lp-PLA2 activity level and the correlation between Lp-PLA2 activityand risk factors were analysed in men and women.
Results
1. Lp-PLA2 activity was higher in males than in females (22.73 ± 8.52 nmol·min-1·ml-1 vs. 20.01 ± 8.06 nmol·min-1·ml-1, P < 0.001). 2. Age, waist circumference, systolic blood pressure, diastolic blood pressure and the prevalence of hypertension were higher in males than in females, while total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were higher in females than in males. 3. Lp-PLA2 activity was significantly correlated with lipids (LDL-C, total cholesterol, triglyceride, and HDL-C), blood pressure (systolic blood pressure and diastolic blood pressure), and adiposity associated parameters (waist circumference and BMI) in males; it was significantly correlated with lipid level (LDL-C, total cholesterol, triglyceride, and HDL-C) and age in females, while its correlation with variables associated with obesity or blood pressure were much weaker than those in males. 4. After adjustment for age, waist circumference, LDL-C, HDL-C, triglyceride, systolic blood pressure, glucose and high sensitivity C-reactive protein by Logistic regression model, Lp-PLA2 activity was still significantly higher in males than in females (OR = 1.72, 95% confidence interval = 1.34-2.21).
Conclusions
The level of Lp-PLA2 activity and its association with known cardiovascular risk factors differed in males and females. The gender difference in Lp-PLA2 activity cannot be fully explained by known cardiovascular risk factors.
Title: GW24-e0047 Gender Difference in Lipoprotein-Associated Phospholipase A2 Activity and Its Association with Cardiovascular Risk Factors
Description:
Objectives
Lipoprotein-associated phospholipase A2(Lp-PLA2), a proinflammatory enzyme secreted primarily by macrophages, has been shown to be a predictor and potential therapeutic target of cardiovascular disease.
The level and distribution of Lp-PLA2 and its associated factors are still unknown for Chinese population.
Therefore, we aimed to study the level of Lp-PLA2 activity in men and women in a general population, and to investigate the association of Lp-PLA2 with known cardiovascular risk factors.
Methods
A total of 1471 participants aged 45-74 were recruited from a cohort study in Beijing.
Lp-PLA2 activity was determined by a colorimetric assay kit (Cayman Chemical, Ann Arbour, USA).
Lp-PLA2 activity level and the correlation between Lp-PLA2 activityand risk factors were analysed in men and women.
Results
1.
Lp-PLA2 activity was higher in males than in females (22.
73 ± 8.
52 nmol·min-1·ml-1 vs.
20.
01 ± 8.
06 nmol·min-1·ml-1, P < 0.
001).
2.
Age, waist circumference, systolic blood pressure, diastolic blood pressure and the prevalence of hypertension were higher in males than in females, while total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were higher in females than in males.
3.
Lp-PLA2 activity was significantly correlated with lipids (LDL-C, total cholesterol, triglyceride, and HDL-C), blood pressure (systolic blood pressure and diastolic blood pressure), and adiposity associated parameters (waist circumference and BMI) in males; it was significantly correlated with lipid level (LDL-C, total cholesterol, triglyceride, and HDL-C) and age in females, while its correlation with variables associated with obesity or blood pressure were much weaker than those in males.
4.
After adjustment for age, waist circumference, LDL-C, HDL-C, triglyceride, systolic blood pressure, glucose and high sensitivity C-reactive protein by Logistic regression model, Lp-PLA2 activity was still significantly higher in males than in females (OR = 1.
72, 95% confidence interval = 1.
34-2.
21).
Conclusions
The level of Lp-PLA2 activity and its association with known cardiovascular risk factors differed in males and females.
The gender difference in Lp-PLA2 activity cannot be fully explained by known cardiovascular risk factors.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Role of Phospholipase D in Vascular Calcification
Role of Phospholipase D in Vascular Calcification
Le rôle de la phospholipase D dans la calcification vasculaire
La calcification vasculaire est l’accumulation de cristaux de calcium dans les vaisseaux sanguins à t...
Extended lipid profile and urine albumin-creatinine ratio in type 2 diabetes mellitus
Extended lipid profile and urine albumin-creatinine ratio in type 2 diabetes mellitus
Background: Diabetes is a chronic metabolic disorder and has become the one of the most challenging global health problem of 21 st centuary. Diabetic nephropathy is a major complic...
Renal Lipoprotein (a) Metabolism
Renal Lipoprotein (a) Metabolism
The kidney plays a central role in lipoprotein(a) catabolism, acting as a “cemetery for lipoprotein(a)” through uptake, fragmentation, and excretion.
Direct human evidence comes fr...
High lipoprotein(a) and high risk of mortality
High lipoprotein(a) and high risk of mortality
Abstract
Aims
Several lipoprotein(a)-lowering therapies are currently being developed with the long-term goal of reducing...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE
In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Lipoprotein(a) in cardiovascular disease with focus on peripheral arterial disease, major adverse limb events, abdominal aortic aneurysms and interaction with low-grade inflammation
Lipoprotein(a) in cardiovascular disease with focus on peripheral arterial disease, major adverse limb events, abdominal aortic aneurysms and interaction with low-grade inflammation
Lipoprotein(a) is an established risk factor for atherosclerotic cardiovascular disease (ASCVD), with strong evidence of causality from genetic and epidemiological studies. This re...

